Your browser doesn't support javascript.
loading
Short Communication: HIV-DRLink: A Tool for Reporting Linked HIV-1 Drug Resistance Mutations in Large Single-Genome Data Sets Using the Stanford HIV Database.
Shao, Wei; Boltz, Valerie F; Hattori, Junko; Bale, Michael J; Maldarelli, Frank; Coffin, John M; Kearney, Mary F.
Afiliação
  • Shao W; Advanced Biomedical Computing Science, Frederick National Laboratory for Cancer Research (FNLCR) sponsored by the National Cancer Institute, Frederick, Maryland, USA.
  • Boltz VF; HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
  • Hattori J; HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
  • Bale MJ; HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
  • Maldarelli F; HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
  • Coffin JM; Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
  • Kearney MF; HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
AIDS Res Hum Retroviruses ; 36(11): 942-947, 2020 11.
Article em En | MEDLINE | ID: mdl-32683881
ABSTRACT
The prevalence of HIV-1 drug resistance is increasing worldwide and monitoring its emergence is important for the successful management of populations receiving combination antiretroviral therapy. It is likely that pre-existing drug resistance mutations linked on the same viral genomes are predictive of treatment failure. Because of the large number of sequences generated by ultrasensitive single-genome sequencing (uSGS) and other similar next-generation sequencing methods, it is difficult to assess each sequence individually for linked drug resistance mutations. Several software/programs exist to report the frequencies of individual mutations in large data sets, but they provide no information on linkage of resistance mutations. In this study, we report the HIV-DRLink program, a research tool that provides resistance mutation frequencies as well as their genetic linkage by parsing and summarizing the Sierra output from the Stanford HIV Database. The HIV-DRLink program should only be used on data sets generated by methods that eliminate artifacts due to polymerase chain reaction recombination, for example, standard single-genome sequencing or uSGS. HIV-DRLink is exclusively a research tool and is not intended to inform clinical decisions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Idioma: En Ano de publicação: 2020 Tipo de documento: Article